Corbus Pharmaceuticals Holdings, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $102.3M
Liabilities Breakdown FY2020
Total Liabilities: $57.0M
Asset Breakdown
Total Assets: $102.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $85.4M | 83.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.1M | 4.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $12.8M | 12.5% |
Liabilities Breakdown
Total Liabilities: $57.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.4M | 12.9% |
| Long-Term Debt | $18.0M | 31.6% |
| Other Liabilities | $31.6M | 55.4% |